Hypertension, Portal
Showing 26 - 50 of 8,512
Portal Hypertension, Variceal Hemorrhage, Ulcer Hemorrhage Trial in Alexandria (Vonoprazan fumarate (Vonaspire), Pantoprazole
Completed
- Portal Hypertension
- +2 more
- Vonoprazan fumarate (Vonaspire)
- +2 more
-
Alexandria, EgyptAlexandria Main University Hospital
Nov 15, 2022
Cera™ Vascular Plug System Post-Market Clinical Follow-Up
Not yet recruiting
- Aneurysm
- +5 more
- Cera™ Vascular Plug System
- (no location specified)
Oct 22, 2023
Intrahepatic Non Cirrhotic Portal Hypertension Trial in Clichy (Apixaban, Placebo)
Recruiting
- Intrahepatic Non Cirrhotic Portal Hypertension
- Apixaban
- Placebo
-
Clichy, FranceBeaujon hospital
Mar 21, 2022
Relevance of Sarcopenia in Advanced Liver Disease
Recruiting
- Liver Cirrhosis
- +3 more
-
Linköping, SwedenDepartment of gastroenterology and hepatology
Aug 12, 2022
The vPPG-detecting Software Guided Management of Cirrhotic
Active, not recruiting
- Portal Hypertension
- Cirrhosis, Liver
- PPG-detecting software
- LSM and PLT count
-
Shanghai, ChinaShanghai Tongji Hospital, Tongji University School of Medicine
May 13, 2022
Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular
Recruiting
- Cirrhosis
- +3 more
- Apixaban 2.5 MG
- +2 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College, Yangzhou University
Apr 30, 2022
Cirrhotic Patients Undergoing Liver Transplantation
Completed
- Liver Transplantation
- +3 more
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal (CHUM)
Jul 21, 2022
Portal Hypertension Trial in Minneapolis (Particle, Coil)
Withdrawn
- Portal Hypertension
- Particle
- Coil
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 17, 2022
Portal Hypertension, Gastric Varices Bleeding, Portosystemic Shunt Trial (preemptive TIPS, standard second prophylaxis)
Not yet recruiting
- Portal Hypertension
- +2 more
- preemptive TIPS
- standard second prophylaxis
- (no location specified)
Nov 3, 2023
Liver Cirrhosis, Portal Hypertension, Ascites Trial in Vienna
Recruiting
- Liver Cirrhosis
- +4 more
-
Vienna, AustriaMedical University of Vienna
Oct 9, 2022
Portal Hypertension Trial in Nanjing (Endoscopy+NSBBs, Transjugular intrahepatic portosystemic shunt)
Recruiting
- Portal Hypertension
- Endoscopy+NSBBs
- Transjugular intrahepatic portosystemic shunt
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Aug 22, 2023
Liver Diseases, Portal Hypertension Trial in Philadelphia, Bern (SHAPE measurement (Sonazoid ultrasoud contrast agent), SHAPE
Not yet recruiting
- Liver Diseases
- Portal Hypertension
- SHAPE measurement (Sonazoid ultrasoud contrast agent)
- SHAPE measurement (Definity ultrasoud contrast agent)
-
Philadelphia, Pennsylvania
- +2 more
Jul 20, 2022
Cirrhosis, Liver, Portal Hypertension, Ascites Hepatic Trial in San Francisco (Withings Home Blood Pressure Device and Scale,
Recruiting
- Cirrhosis, Liver
- +2 more
- Withings Home Blood Pressure Device and Scale
- Standard of Care
-
San Francisco, CaliforniaUniversity of California San Francisco
Jun 30, 2023
Hypertension, Portal Trial in Philadelphia (SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane
Recruiting
- Hypertension, Portal
- SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)
- SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Jan 20, 2022
Cirrhosis, Portal Hypertension, Exercise Trial (Exercise, nutritional therapy)
Completed
- Cirrhosis
- +2 more
- Exercise
- nutritional therapy
- (no location specified)
Aug 31, 2022
Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
Not yet recruiting
- Hepatocellular Carcinoma
- Portal Hypertension
- TACE ± Systemic therapy
-
Nanjing, China
- +1 more
Jan 28, 2023
Liver and Spleen Stiffness Measured by TE and 2D-SWE for
Recruiting
- Liver Cirrhosis
- +2 more
- Transient elastography (TE) and 2D-shear wave elastography (2D-SWE)
-
Zhuhai, Guangdong, ChinaThe Fifth Affiliated Hospital, Sun Yat-sen University
Nov 16, 2023
The Precise Selection of Stent Diameter for Portal Hypertension
Recruiting
- Compensated Advanced Chronic Liver Disease
- Portal Hypertension
- a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient
-
Hangzhou, ChinaFirst Affiliated Hospital of Zhejiang University
Mar 17, 2022
Acute Kidney Injury, Cirrhosis, Portal Hypertension Trial in San Francisco (MAP-Target Algorithm)
Not yet recruiting
- Acute Kidney Injury
- +5 more
- MAP-Target Algorithm
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 14, 2023
Based on Smartphone-derived Multimodality Images to Evaluate
Recruiting
- Portal Hypertension
- Hepatic venous pressure gradient
-
Beijing, Beijing, China
- +1 more
May 30, 2022
Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)
Recruiting
- Cirrhosis
- +3 more
- Apixaban
- +4 more
-
Yangzhou, Jiangsu, ChinaClinical Medical College of Yangzhou University
Mar 19, 2022
Portal Hypertension, Chronic Advanced Liver Disease Trial in Indianapolis (Liver Incytes)
Recruiting
- Portal Hypertension
- Chronic Advanced Liver Disease
- Liver Incytes
-
Indianapolis, IndianaIndiana University Division of Gastroenterolgy and Hepatology
Jan 25, 2022
Cirrhosis, Liver, Portal Hypertension, Variceal Hemorrhage Trial in London (Carvedilol, Placebo)
Recruiting
- Cirrhosis, Liver
- +3 more
- Carvedilol
- Placebo
-
London, United KingdomKing's College Hospital
May 23, 2023
Cirrhosis, Liver, Portal Hypertension Trial in Ann Arbor, Philadelphia, Dallas (Enhanced Usual Care, Lactulose, Investigator
Not yet recruiting
- Cirrhosis, Liver
- Portal Hypertension
- Enhanced Usual Care
- +3 more
-
Ann Arbor, Michigan
- +2 more
Mar 20, 2023